Hakim Unique Group

Hakim Unique Group is a private Chinese conglomerate and investment group based in Hangzhou, Zhejiang, with activities spanning healthcare, technology, finance, and media. In healthcare, the group appears to operate primarily as an investor, holding company, and business development platform rather than as a pure-play drug developer. Publicly visible healthcare-related activities include investment in California Healthcom Group and operation of Great Health Companion Group, which has been involved in exploring China partnerships for clinical-stage assets such as Kinarus Therapeutics' KIN001. Available public information does not indicate that Hakim Unique Group itself runs a disclosed proprietary therapeutic pipeline with named drug candidates. Overall, the company is better characterized as a diversified commercial and investment organization with meaningful healthcare exposure than as a standalone biotech or pharma company.